cotrimoxazole et bactrim

COVID-19 vaccination associated with 15% reduction in stillbirths in pregnant women

A new research paper, published today in Nature Communications, shows that COVID-19 vaccination during pregnancy using mRNA vaccines is associated with a 15% reduction in stillbirths. The paper also shows that vaccination in pregnancy is 90% effective against COVID-19 infection and is safe, with no increased risk in adverse outcomes for women or their babies.

The study, led by researchers from St George’s, University of London and the Royal College of Obstetricians and Gynecologists, reviewed 23 studies including 117, exelon tablets dosage 552 COVID-19 vaccinated pregnant women, almost exclusively with mRNA vaccines, such as those produced by Pfizer and Moderna.

The research provides much-needed assurance to women of the safety and benefits of COVID-19 vaccination in pregnancy. Despite the fact that vaccine uptake in pregnancy in England increased from 23% in August 2021 to 53% in December 2021, nearly half of all pregnant women in the latest data have not yet received this vaccine. One of the reasons that women often give for this hesitancy is concern about the effect of the vaccine on their baby.

Professor of obstetrics and maternal medicine at St George’s, University of London and St George’s Hospital, Asma Khalil, who is the senior author on the paper, said: “Our findings should help to address vaccine hesitancy in pregnant women. Although many things are returning to normal, there is still a very clear and substantial risk of COVID-19 infection for mothers and their babies, including an increased risk of premature birth and stillbirth. It is essential that as many people as possible receive their vaccines to reduce the risk of complications during pregnancy. This paper shows that COVID-19 vaccination is both safe and effective and we hope that this will help to reassure pregnant people to take up their offer of a vaccine going forwards.”

Source: Read Full Article